Healthcare Sector

JNJ

Market Tracker

$202.39
+2.39
(+1.19%)
12:00 am
Next Earnings: (est.) 07/20/23 12:00 am
  • JNJ (Selected)

    Johnson & Johnson

JNJ Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

JNJ Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

JNJ Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

JNJ Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

JNJ Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

JNJ Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/16/2026 CALL $230.00 2,187 +1,789 +449.50%
01/16/2026 CALL $195.00 5,357 +1,121 +26.46%
01/16/2026 CALL $240.00 1,600 +1,000 +166.67%
01/16/2026 CALL $210.00 4,113 +538 +15.05%
01/16/2026 CALL $220.00 2,129 +512 +31.66%
04/17/2026 CALL $185.00 7,063 +235 +3.44%
12/19/2025 PUT $190.00 0 -4,625 -100.00%
12/19/2025 PUT $195.00 0 -4,872 -100.00%
12/19/2025 CALL $200.00 0 -5,015 -100.00%
12/19/2025 CALL $210.00 0 -5,015 -100.00%
12/19/2025 PUT $200.00 0 -5,015 -100.00%
12/19/2025 CALL $195.00 0 -6,372 -100.00%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

JNJ Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.55% 79.47M 12.56B
Vanguard 500 Index Fund 1.94% 60.44M 9.55B
Fidelity 500 Index Fund 0.92% 28.66M 4.53B
SPDR S&P 500 ETF Trust 0.91% 28.31M 4.47B
iShares Core S&P 500 ETF 0.75% 23.33M 3.69B
Vanguard Index-Value Index Fund 0.72% 22.6M 3.57B
Select Sector SPDR Fund-Health Care 0.68% 21.24M 3.36B
Vanguard Institutional Index Fund-Institutional Index Fund 0.59% 18.32M 2.9B
Vanguard Specialized-Dividend Appreciation Index Fund 0.53% 16.62M 2.63B
Washington Mutual Investors Fund 0.40% 12.37M 1.96B

JNJ News

  • Why Johnson & Johnson's Share Price Is Popping This Month

    11/19 01:24 pm

    The Motley Fool

    Read more
  • Hospital Care Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 726 Deals by Company A-Z, Therapy Focus and Technology Type

    11/19 11:59 am

    GlobeNewswire Inc.

    Read more
  • 5 Dividend Aristocrats I Recommend Now

    11/19 03:01 am

    Investing.com

    Read more
  • Nailing Systems Market Set for Strong Growth as Demand Rises Across Orthopedic and Trauma Care Segments: Verified Market Research®

    11/18 11:45 pm

    GlobeNewswire Inc.

    Read more
  • AI in Medical Devices Market Expands to USD 886.39 Billion by 2034 – reports Towards Healthcare

    11/18 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Johnson & Johnson Adds Prostate Cancer Candidate In Around $3 Billion Halda Deal

    11/17 01:23 pm

    Benzinga

    Read more
  • Halda Therapeutics Announces Acquisition by Johnson & Johnson

    11/17 09:15 am

    Benzinga

    Read more
  • Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update

    11/14 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy

    11/14 12:17 pm

    Benzinga

    Read more
  • 2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon

    11/13 06:04 am

    The Motley Fool

    Read more
  • Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

    11/12 12:01 pm

    The Motley Fool

    Read more
  • Breast Implants Market to Surpass USD 5.62 Billion by 2034, Driven by Rising Breast Cancer Cases and Aesthetic Surgery Demand

    11/11 09:00 am

    GlobeNewswire Inc.

    Read more
  • Got $1,000? Here Are the Smartest Dividend Stocks to Start With.

    11/10 05:15 am

    The Motley Fool

    Read more
  • Lamar Advertising (LAMR) Q3 2025 Earnings Call Transcript

    11/06 12:10 pm

    The Motley Fool

    Read more
  • High Concentration mAb Products Market Advancing Precision Biopharmaceutical Therapeutics – Towards Healthcare

    11/06 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Alvotech og Advanz Pharma fá markaðsleyfi í Bretlandi fyrir Gobivaz, hliðstæðu við Simponi (golimumab)

    11/06 10:00 am

    GlobeNewswire Inc.

    Read more
  • Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA

    11/06 10:00 am

    GlobeNewswire Inc.

    Read more
  • AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

    11/04 08:00 am

    GlobeNewswire Inc.

    Read more
  • These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors?

    11/04 04:23 am

    The Motley Fool

    Read more
  • Alvotech Shares Plunge 33% After FDA Flags Issues

    11/03 02:17 pm

    Benzinga

    Read more
  • Pelvic Inflammatory Disease Treatment Market to Reach USD 5.09 Billion by 2034, Driven by Rising STI Cases and Growing Awareness

    11/03 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?

    11/03 08:16 am

    Benzinga

    Read more
  • Multiple Myeloma Research Foundation Joins Forces with Patients and Caregivers for Road to Victories Fundraiser

    11/03 08:00 am

    GlobeNewswire Inc.

    Read more
  • Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks?

    11/03 07:15 am

    The Motley Fool

    Read more
  • Pharmaceutical Market to Reach USD 3,033.21 Billion by 2034 Driven by Rising Geriatric Population

    10/29 11:00 am

    GlobeNewswire Inc.

    Read more
  • Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety

    10/28 01:11 pm

    Benzinga

    Read more
  • Joint Reconstruction Devices Market 2025-2032: New Technologies are Transforming the Landscape, Reaching $149 Billion by 2032

    10/27 09:00 am

    GlobeNewswire Inc.

    Read more
  • FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep

    10/24 10:23 am

    Benzinga

    Read more
  • Inside Dow Jones: Key Earnings Ahead for Some of the Index YTD Winners

    10/22 10:40 am

    Investing.com

    Read more
  • Global Cataract Surgery Devices Market to Grow at a CAGR of ~5% Driven by Innovation and Increasing Patient Awareness | DelveInsight

    10/21 01:00 pm

    GlobeNewswire Inc.

    Read more
  • SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

    10/21 07:00 am

    GlobeNewswire Inc.

    Read more
  • Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb

    10/20 10:57 am

    Benzinga

    Read more
  • 2 Top Dividend Kings Every Income Investor Should Own

    10/20 05:05 am

    The Motley Fool

    Read more
  • Meet the 5%-Yielding Dividend Stock That Could Soar in 2026

    10/19 01:25 pm

    The Motley Fool

    Read more
  • Subcutaneous RYBREVANT®▼(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer

    10/19 10:35 am

    GlobeNewswire Inc.

    Read more
  • Why Kenvue Stock Tumbled by 13% on Thursday

    10/16 06:06 pm

    The Motley Fool

    Read more
  • Johnson & Johnson Builds Momentum as Margin Expansion Strategy Takes Hold

    10/16 02:08 pm

    Investing.com

    Read more
  • Johnson & Johnson Reports Strong Phase 3 Results For Multiple Myeloma Therapy

    10/16 01:37 pm

    Benzinga

    Read more
  • Johnson & Johnson Reportedly Faces Major UK Lawsuit Over Baby Powder Cancer Risks

    10/16 09:09 am

    Benzinga

    Read more
  • 2 Dividend Stocks I'm Very Thankful I Owned This Year

    10/15 01:03 pm

    The Motley Fool

    Read more
  • This 2.7%-Yielding Dividend King Remains One of the Healthiest Income Stocks You Can Buy

    10/15 05:20 am

    The Motley Fool

    Read more
  • Johnson & Johnson To Separate Orthopedics Business, Boosts Annual Sales Outlook

    10/14 08:51 am

    Benzinga

    Read more
  • FDA Adds New Warning For Johnson & Johnson's Cancer Cell Therapy

    10/13 10:30 am

    Benzinga

    Read more
  • Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?

    10/13 06:10 am

    The Motley Fool

    Read more
  • Douglas Lane Adds $6 Million in J&J Stock Ahead of Earnings and Possible Biotech Deal

    10/12 03:14 pm

    The Motley Fool

    Read more
  • Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today

    10/10 07:07 pm

    The Motley Fool

    Read more
  • Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report

    10/10 01:06 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: